Association of hyperuricemia with higher miscarriage rates and lower live birth rates in women undergoing IVF/ICSI

Abstract Background Hyperuricemia (HUA) has become popular globally, being an important risk factor for various metabolic diseases. Elevated serum uric acid (UA) levels cause adverse reproductive outcomes in women with polycystic ovary syndrome undergoing assisted reproductive technology (ART). Howe...

Full description

Saved in:
Bibliographic Details
Main Authors: Ling Zhou, Jiahuan Luo, Shuhua Zhao, Longda Wang, Meng Rao, Huawei Wang, Li Tang
Format: Article
Language:English
Published: BMC 2025-07-01
Series:Journal of Ovarian Research
Subjects:
Online Access:https://doi.org/10.1186/s13048-025-01720-4
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849238438558040064
author Ling Zhou
Jiahuan Luo
Shuhua Zhao
Longda Wang
Meng Rao
Huawei Wang
Li Tang
author_facet Ling Zhou
Jiahuan Luo
Shuhua Zhao
Longda Wang
Meng Rao
Huawei Wang
Li Tang
author_sort Ling Zhou
collection DOAJ
description Abstract Background Hyperuricemia (HUA) has become popular globally, being an important risk factor for various metabolic diseases. Elevated serum uric acid (UA) levels cause adverse reproductive outcomes in women with polycystic ovary syndrome undergoing assisted reproductive technology (ART). However, its impact on reproductive outcomes in the general population is unknown. Method This retrospective study was conducted on a general population of infertility patients at a single center (March 2016-April 2023). Overall, 2189 first transfer cycles were screened for inclusion. HUA was defined as serum UA ≥ 360 µmol/L. Variables identified by LASSO regression analysis were entered into logistic regression models to calculate odds ratios. Generalized additive models were employed to examine the nonlinear relationship between serum UA as a continuous variable with outcomes. The primary outcome was live birth rate (LBR). Results Baseline characteristics revealed that HUA patients presented with significantly elevated metabolic parameters, including higher BMI, fasting glucose, lipid profiles, and greater prevalence of polycystic ovarian syndrome. Patients with HUA demonstrated significantly lower LBR and fertilization rates, along with higher miscarriage rates, while no significant differences were observed in oocyte retrieval numbers, embryo utilization rates, high-quality cleavage embryo formation, blastocyst formation rates, or clinical pregnancy rates (CPR). After adjusting for confounding variables, HUA remained a significant factor affecting LBR and miscarriage rate. Notably, the detrimental effects of HUA exhibited modality-specific patterns, with frozen-thawed embryo transfer (FET) cycles demonstrating greater vulnerability to HUA than fresh transfers. Among younger women, HUA independently predicted reduced LBR and increased miscarriage risk, with no significant association observed in those ≥ 35 years. And this effect remained significant in normal-weight (< 24 kg/m2) women but not in overweight individuals. Conclusion Elevated UA levels are linked to lower LBR and higher miscarriage risk in ART, especially in younger, non-obese women where HUA is an independent risk factor. Though not affecting embryo quality or implantation, HUA may impair pregnancy maintenance. Even in older or overweight patients, UA monitoring remains important. Routine assessment and tailored management—particularly greater attention to pregnancy loss and cautious use of programmed FET in poorly controlled cases—may help improve ART outcomes.
format Article
id doaj-art-105a0ad796f04e8da67f08e5ffb2e1f8
institution Kabale University
issn 1757-2215
language English
publishDate 2025-07-01
publisher BMC
record_format Article
series Journal of Ovarian Research
spelling doaj-art-105a0ad796f04e8da67f08e5ffb2e1f82025-08-20T04:01:36ZengBMCJournal of Ovarian Research1757-22152025-07-0118111510.1186/s13048-025-01720-4Association of hyperuricemia with higher miscarriage rates and lower live birth rates in women undergoing IVF/ICSILing Zhou0Jiahuan Luo1Shuhua Zhao2Longda Wang3Meng Rao4Huawei Wang5Li Tang6Department of Reproduction and Genetics, The First Affiliated Hospital of Kunming Medical UniversityDepartment of Reproduction and Genetics, The First Affiliated Hospital of Kunming Medical UniversityDepartment of Reproduction and Genetics, The First Affiliated Hospital of Kunming Medical UniversityDepartment of Reproduction and Genetics, The First Affiliated Hospital of Kunming Medical UniversityDepartment of Reproduction and Genetics, The First Affiliated Hospital of Kunming Medical UniversityDepartment of Reproduction and Genetics, The First Affiliated Hospital of Kunming Medical UniversityDepartment of Reproduction and Genetics, The First Affiliated Hospital of Kunming Medical UniversityAbstract Background Hyperuricemia (HUA) has become popular globally, being an important risk factor for various metabolic diseases. Elevated serum uric acid (UA) levels cause adverse reproductive outcomes in women with polycystic ovary syndrome undergoing assisted reproductive technology (ART). However, its impact on reproductive outcomes in the general population is unknown. Method This retrospective study was conducted on a general population of infertility patients at a single center (March 2016-April 2023). Overall, 2189 first transfer cycles were screened for inclusion. HUA was defined as serum UA ≥ 360 µmol/L. Variables identified by LASSO regression analysis were entered into logistic regression models to calculate odds ratios. Generalized additive models were employed to examine the nonlinear relationship between serum UA as a continuous variable with outcomes. The primary outcome was live birth rate (LBR). Results Baseline characteristics revealed that HUA patients presented with significantly elevated metabolic parameters, including higher BMI, fasting glucose, lipid profiles, and greater prevalence of polycystic ovarian syndrome. Patients with HUA demonstrated significantly lower LBR and fertilization rates, along with higher miscarriage rates, while no significant differences were observed in oocyte retrieval numbers, embryo utilization rates, high-quality cleavage embryo formation, blastocyst formation rates, or clinical pregnancy rates (CPR). After adjusting for confounding variables, HUA remained a significant factor affecting LBR and miscarriage rate. Notably, the detrimental effects of HUA exhibited modality-specific patterns, with frozen-thawed embryo transfer (FET) cycles demonstrating greater vulnerability to HUA than fresh transfers. Among younger women, HUA independently predicted reduced LBR and increased miscarriage risk, with no significant association observed in those ≥ 35 years. And this effect remained significant in normal-weight (< 24 kg/m2) women but not in overweight individuals. Conclusion Elevated UA levels are linked to lower LBR and higher miscarriage risk in ART, especially in younger, non-obese women where HUA is an independent risk factor. Though not affecting embryo quality or implantation, HUA may impair pregnancy maintenance. Even in older or overweight patients, UA monitoring remains important. Routine assessment and tailored management—particularly greater attention to pregnancy loss and cautious use of programmed FET in poorly controlled cases—may help improve ART outcomes.https://doi.org/10.1186/s13048-025-01720-4Assisted reproduction technologyHyperuricemiaLive birthMiscarriage
spellingShingle Ling Zhou
Jiahuan Luo
Shuhua Zhao
Longda Wang
Meng Rao
Huawei Wang
Li Tang
Association of hyperuricemia with higher miscarriage rates and lower live birth rates in women undergoing IVF/ICSI
Journal of Ovarian Research
Assisted reproduction technology
Hyperuricemia
Live birth
Miscarriage
title Association of hyperuricemia with higher miscarriage rates and lower live birth rates in women undergoing IVF/ICSI
title_full Association of hyperuricemia with higher miscarriage rates and lower live birth rates in women undergoing IVF/ICSI
title_fullStr Association of hyperuricemia with higher miscarriage rates and lower live birth rates in women undergoing IVF/ICSI
title_full_unstemmed Association of hyperuricemia with higher miscarriage rates and lower live birth rates in women undergoing IVF/ICSI
title_short Association of hyperuricemia with higher miscarriage rates and lower live birth rates in women undergoing IVF/ICSI
title_sort association of hyperuricemia with higher miscarriage rates and lower live birth rates in women undergoing ivf icsi
topic Assisted reproduction technology
Hyperuricemia
Live birth
Miscarriage
url https://doi.org/10.1186/s13048-025-01720-4
work_keys_str_mv AT lingzhou associationofhyperuricemiawithhighermiscarriageratesandlowerlivebirthratesinwomenundergoingivficsi
AT jiahuanluo associationofhyperuricemiawithhighermiscarriageratesandlowerlivebirthratesinwomenundergoingivficsi
AT shuhuazhao associationofhyperuricemiawithhighermiscarriageratesandlowerlivebirthratesinwomenundergoingivficsi
AT longdawang associationofhyperuricemiawithhighermiscarriageratesandlowerlivebirthratesinwomenundergoingivficsi
AT mengrao associationofhyperuricemiawithhighermiscarriageratesandlowerlivebirthratesinwomenundergoingivficsi
AT huaweiwang associationofhyperuricemiawithhighermiscarriageratesandlowerlivebirthratesinwomenundergoingivficsi
AT litang associationofhyperuricemiawithhighermiscarriageratesandlowerlivebirthratesinwomenundergoingivficsi